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Abstract Tissue engineering is essentially a technique
for imitating nature. Natural tissues consist of three com-
ponents: cells, signalling systems (e.g. growth factors) and
extracellular matrix (ECM). The ECM forms a scaffold for
its cells. Hence, the engineered tissue construct is an arti-
ficial scaffold populated with living cells and signalling
molecules. A huge effort has been invested in bone tissue
engineering, in which a highly porous scaffold plays a
critical role in guiding bone and vascular tissue growth and
regeneration in three dimensions. In the last two decades,
numerous scaffolding techniques have been developed to
fabricate highly interconnective, porous scaffolds for bone
tissue engineering applications. This review provides an
update on the progress of foaming technology of bioma-
terials, with a special attention being focused on computer-
aided manufacturing (Andrade et al. 2002) techniques. This
article starts with a brief introduction of tissue engineering
(Bone tissue engineering and scaffolds) and scaffolding
materials (Biomaterials used in bone tissue engineering).
After a brief reviews on conventional scaffolding tech-
niques (Conventional scaffolding techniques), a number of
CAM techniques are reviewed in great detail. For each
technique, the structure and mechanical integrity of fabri-
cated scaffolds are discussed in detail. Finally, the advan-
taged and disadvantage of these techniques are compared
(Comparison of scaffolding techniques) and summarised
(Summary).
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Bone tissue engineering and scaffolds
Tissue engineering is defined as a multidisciplinary scien-
tific branch that combines cell biology, materials science
and engineering, and regenerative medicine (Langer and
Vacanti 1993). This innovative technology has attracted
increasing attention as an alternative strategy to treat
damaged organs and tissues that cannot be self-regener-
ated, such as full-thickness skin burn, over critical-sized
bone defects, and chronic cartilage disease. Tissue engi-
neering aims to eliminate the disadvantages of the con-
ventional clinical treatments (Burg et al. 2000) associated
with donor-site morbidity and scarcity in autografting and
allografting (allografting also introduces the risk of disease
and infection transmission). Developed as an artificial bone
matrix, a tissue engineering scaffold plays an essential role
in regenerating bone tissue.
In general, a tissue engineering process begins with the
fabrication of a biologically compatible scaffold that will
support living cells for their attachment, proliferation and
differentiation, and thus promote tissue regeneration both
in vitro and in vivo. Ideally, a tissue engineering scaffold
should be biocompatible, biodegradable, highly porous and
interconnected, and mechanically reliable. To engineer
bone, which is a vascularised tissue, a well-interconnected
porosity is highly desirable for the sake of vascularisation.
Appropriate mechanical strength is another important
requirement for implants at load-bearing sites. The specific
criteria of an ideal scaffold in bone tissue engineering are
summarised in Table 1.
Biomaterials used in bone tissue engineering
The selection and design of a bone matrix-like biomaterial
are primarily determined by the composition of the osseous
tissue. The extracellular matrix (ECM) of bone is a com-
posite that primarily comprises hydroxyapatite (HA) (bio-
logical ceramics) embedded within a collagen matrix
(biological polymers) and water. Table 2 provides the
composition of the natural bone matrix. Not surprisingly,
scaffolding biomaterials applied to bone tissue engineering
are principally made from (1) natural or synthetic poly-
mers, (2) ceramics or (3) their composites aimed at mim-
icking the composition and structure of natural bone
(Vacanti 2000; Correlo et al. 2011; Wolfe et al. 2011;
Reichert and Hutmacher 2011). For this reason, this section
is devoted to a concise review on these promising scaf-
folding biomaterials, focusing on biocompatibility,
Table 1 Criteria of an ideal scaffold for bone tissue engineering
(Bruder and Caplan 2000; Chen et al. 2008; Liu et al. 2013)
Criteria Requirement
Biocompatibility Support and foster cells’ attachment,
proliferation and differentiation, and initiate
tissue regeneration both in vitro and in vivo
Osteoconductivity Encourage host bone adherence and growth into
the scaffold




Maintain proper mechanical stability for tissue
regeneration
Porous structure Be highly porous ([90 %) and interconnected,
with pore diameters between 300 and 500 lm,
to allow cells to penetrate into a pore structure,
and promote new bone formation, as well as
vascularisation. It must be able to deliver
nutrients into the scaffold and transport
undesirable metabolites outside scaffold
Fabrication Possess desired fabrication capabilities (e.g.
being readily produced into irregular shapes of
scaffolds that match the defects in the bone of
individual patients)
Commercialisation Be fabricated at an acceptable cost for
commercialisation
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biodegradability, and mechanical properties, which are the




Much research effort has been invested in the fabrication of
scaffolds from naturally derived biopolymers, including
collagen, demineralised ECM-based materials, and chito-
san and its derivative for the purpose of bone tissue engi-
neering. Due to their excellent biocompatibility, naturally
derived biopolymers generally do not cause significant
inflammatory responses when implanted into the body.
Collagen and ECM-degenerated proteins (i.e. gelatine)
have gained early attention as biomaterials used for bone
tissue engineering due to their advantages, such as excel-
lent biocompatibility, biodegradability and cell-binding
properties (Burg et al. 2000; Russell and Block 1999;
Dawson et al. 2008; Eslaminejad et al. 2007; Sharifi et al.
2011). However, there are serious concerns associated with
the immunogenicity, rapid degradation, and poor mechan-
ical properties of collagen. To minimise these drawbacks,
efforts have been invested in the development of chemical
cross-linked collagen combined with synthetic polymers
(Ferreira et al. 2012; Wojtowicz et al. 2010). Chitosan and
its derivative are another group of natural biopolymers.
They have been widely explored for bone tissue engi-
neering because of their hydrophilic surfaces that promote
cell attachment, proliferation and differentiation (Brown
and Hoffman 2002; Thein-Han and Misra 2009). In addi-
tion to the enhanced osteoconductivity (the process in
which growth of bone on the biomaterial surface) in vivo,
chitosan also exhibits an ability to entrap growth factors at
the wound site (Muzzarelli et al. 1993; Muzzarelli and
Muzzarelli 2005).
Synthetic polymers
Although the naturally derived biopolymers offer benefits
as mentioned above, their use may be limited owing to
poor mechanical properties and a high degradation rate.
Following efforts using naturally occurring polymers as
scaffolds, attention has been paid to synthetic polymers.
Besides being biocompatible and biodegradable, synthetic
polymers offer advantages over the biologically derived
biopolymers. These include controllable degradation rate,
predictable and reproducible mechanical properties, and
ease of fabrication with tailorable shapes and sizes as
required (Wolfe et al. 2011; Vacanti et al. 2000; Middleton
and Tipton 2000; Puppi et al. 2010; Dhandayuthapani et al.
2011). Further, synthetic polymers have a long shelf life
and can be sterilised. However, they may involve short-
comings such as eliciting persistent inflammatory reactions
when eroded, or they may be mechanically incompliant or
unable to integrate with host tissues. It has been envisaged
that such shortcomings might be overcome by selecting an
appropriate synthetic biopolymer and by the modification
and functionalization of their structures for the specific
tissue engineering purposes (Tian et al. 2012).
The degradable synthetic polymers, which have widely
been used as scaffolding materials in bone tissue engi-
neering, are polyesters. Polyesters are characterised by the
ester functional groups along their backbones, which are
formed via the condensation polymerisation between car-
boxylic acid group (–COOH) and a hydroxyl group (–OH)
on the precursor monomers. Two widely used monomers
are lactic acid and glycolic acid. These small precursor
molecules are endogenous to the human metabolism. In
principle, polyesters can degrade to natural metabolic
products through hydrolysis. Saturated poly(a-hydroxy
esters) such as poly(lactic acid) (PLA), poly(glycolic acid)
(PGA), poly(e-caprolactone) (PCL), and their copolymers
have been extensively investigated (Mano et al. 2004;
Kohn 1996; Rezwan et al. 2006).
PLA was the first polyester studied for application in
tissue engineering because of its biocompatibility and bio-
degradability. It has three stereoisomers: poly(L-lactic acid)
(PLLA), poly(D-lactic acid) (PDLA), and poly(D,L-lactic
acid) (PDLLA). Among these stereoisomers, PDLLA is of
particular interest for scaffold production in bone tissue
engineering application, because it possesses excellent
biocompatibility in vivo and good osteoinductivity (the
process of stimulating the proliferation and differentiation
of progenitor or osteogenic cells) (Schmidmaier et al. 2001).
PGA is employed as a scaffolding material because of
its relatively hydrophilic nature. Both PLA and PGA
undergo bulk erosion via ester linkage hydrolysis into the
degradation products, lactic acid or glycolic acid that are
natural metabolites. However, PGA degrades rapidly in
Table 2 Composition of natural bone matrix
Composition Content and function
Biological
ceramic
Carbonated HA Ca10(PO4)6(OH)2 accounts for
approximately 70 % of the weight of bone. The




Roughly one-third of the weight of bone is
composed of the organic matter, which is primarily
type I collagen and ground substance. Type I
collagen fibres are elastic and flexible, and thus
tolerate stretching, twisting, and bending. Bone
collagen differs slightly from soft-tissue collagen
of the same type in having a great number of
intermolecular cross-links. Ground substance
contains proteoglycans aggregates and several
specific structural glycoproteins
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aqueous solution and the in vivo environment, being
completely resorbed within 4–6 months, which leads to
premature mechanical failures of scaffolds (Wolfe et al.
2011; Ma and Langer 1995; Langer et al. 1995). Hence,
PGA alone is limited for use in scaffolds for bone tissue
engineering. The degradation rates of PLA and PGA can be
ranked in the following order (Rezwan et al. 2006).
PGLA > PGA > PDLLA > PLLA
Decreasing degradation rate
PCL is similar to PLA and PGA but it has a much slower
degradation rate, primarily due to its high crystallinity.
Owing to the ability to promote osteoblast growth and
maintain its phenotype, PCL scaffold has been used as a
long-term implant in the field of bone tissue engineering
(Woodruff and Hutmacher 2010; Pitt et al. 1981; Rich et al.
2002). However, the synthesis of PCL with other fast-
degradable polymers can tune degradation kinetics of these
polymers. Selected physical properties of the polyesters
being discussed are listed in Table 3.
These polyesters remain popular for a variety of reasons,
predominantly excellent biocompatibility and biodegrad-
ability. These materials have chemical properties that allow
hydrolytic degradation through de-esterification. Once
degraded, the acidic products of each polymer can be
metabolised through various physiological pathways by
tissues. For example, PLA can be cleared through tricar-
boxylic acid cycle. Due to their degradation properties,
these polymers have been used in medical devices
approved by the United States Food and Drug Adminis-
tration (FDA) for human clinical uses, such as surgical
sutures. However, release of acidic degradation products
can cause a severe inflammatory response in the body
(Bergsma et al. 1993; Tam et al. 1996; Martin et al. 1996;
Suuronen et al. 1998; Tatakis and Trombelli 1999; Bost-
man and Pihlajamaki 2000).
Since the 1990s, other types of aliphatic polyester:
polyhydroxyalkanoates (PHA) particularly poly-3-
hydroxybutyrate (P3HB), copolymer of 3-hydroxybutyrate
and 3-hydroxyvalerate (PHBV), poly-4-hydroxybutyrate
(P4HB), copolymers of 3-hydroxybutyrate and 3-hydroxy-
hexanoate (PHBHHx) and poly-3-hydroxyoctanoate (Leong
et al. 2007) have been increasingly investigated as scaf-
folding materials for tissue engineering application due to
their high biocompatibility (Chen and Wu 2005; Misra et al.
2006). They are natural thermoplastic polyesters produced
by a wide variety of microorganisms under imbalanced
growth conditions (Doi et al. 1995; Li et al. 2005). Their
wide biodegradation kinetics can be tuned via thermal
processing, and this makes PHAs attractive as biomaterials
for a wider range of applications in medical devices.
The mechanical properties of PHAs can be widely
adjusted by blending with either other polymers or inor-
ganic materials to meet the specific requirements of dif-
ferent applications (Chen and Wu 2005; Doi et al. 1995).
P3HB is a tough, brittle polymer, and an important member
of the PHA family. This polymer degrades with no evidence
of an undesirable chronic inflammatory response after up
until 12 months after implantation (Doyle et al. 1991).
However, the limitation of some PHA polymers is their
ineffective large-scale production and the time-consuming
purification process from bacterial cultures that require an
appropriate extraction system (Chen and Wu 2005; Verma
et al. 2002). Hence, the challenge in their utility is to
reduce the cost of production in the extraction procedure at
an industrial scale. In general, the members of the PHA
family degrade more slowly than PLA; typically, they take
longer than 3 years. This low-degradation rate hampers
their application in bone repair, which typically has a
healing rate of several months.
Synthetic elastomers
Over the past 10 years, a number of research articles have
reported on the development and clinical application of
synthetic, biodegradable elastomeric biomaterials for tissue
engineering applications (Chen et al. 2008, 2013). Elasto-
meric polymers (elastomers) have received increasing
attention because they can provide mechanical stability and
sustainable elasticity to tissues and organs without
mechanical irritation to the host (Wang et al. 2002). Among
the many elastomeric polymers, poly(glycerol sebacate)
(PGS) is a tough, synthetic biodegradable cross-linked
elastomer that has been extensively studied for use as a
scaffolding biomaterial in tissue engineering applications
and regenerative medicine (Bettinger 2011). It is synthes-
ised through the polycondensation (esterification) reaction
of tri-functional glycerol, HOCH2CH(OH)CH2OH, and di-
functional sebacic acid (HOOC)(CH2)8(COOH), producing
Table 3 Mechanical properties and degradation time of synthetic









PDLLA Pellet: 35–150a Film or disk:
1.9–2.4
12–16
Film or disk: 29–35
PLLA Pellet: 40–120a Film or disk:
1.2–3.0
[24
Film or disk: 28–50 Fibre: 10–16
Fibre: 870–2,300
PGA Fibre: 340–920 Fibre: 7–14 6–12
PLGA 41.4–55.2 1.4–2.8 Adjustable
PCL 10–15 0.15–0.33 Bulk [24
P3HB 25–45 1.5–1.8 Very slow
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the pre-polymer that can be melt processed or organic sol-
vent processed into various shapes. Then, this pre-polymer
is reacted to form a three-dimensional (3D), loosely cross-
linked polymer. Young’s modulus of PGS is in the range of
0.056–1.2 MPa, and its elongation at break ranges from 41
to 448 %, depending on the synthesis conditions, reported
by Chen et al. (2008).
Chen’s investigation also reported that PGS had a wide
range of degradation kinetics, which can be fine-tuned
through polycondensation processing to match clinical
requirements. Moreover, it showed good biocompatibility
with several cell types. Another study by Li et al. (2013),
investigating the influence of synthesis conditions on the
mechanical properties and cytocompatibility of PGS,
showed that the modulus and ultimate tensile strength
increased with curing duration. In addition, the cell via-
bility of mouse fibroblasts was better for PGS samples with
a higher conversion. The in vivo evaluation showed that
PGS has a favourable tissue response with significantly less
inflammation in comparison with poly(a-hydroxy acid)
(PLGA) (Sundback et al. 2005). Additionally, many
investigations have demonstrated that this elastomer has an
excellent biocompatibility in vivo for tissue engineering
applications (Kemppainen and Hollister 2010; Stuckey
et al. 2010).
However, the rapid degradation of PGSs is believed to
limit their application for use as scaffolding materials in
engineering tissues that typically have healing rates of
several months or years. To overcome these limitations,
making a composite with bioceramics of PGS could be a
potential strategy. For example, the investigation of PGS-
Bioglass composites developed by Liang et al. (2010)
showed that the addition of Bioglass filler to PGS could
be a control of degradation kinetics, which is independent
of the mechanical properties of the composites. In addition,
the composites have significantly improved biocompati-
bility compared with pure PGS.
Bioceramics
Bioceramics can broadly be divided into calcium phos-
phates and bioactive glasses. This section provides a brief
overview on bioceramics, and detailed reviews on most
recent development of bioceramics can be found elsewhere
(Chen et al. 2012).
Calcium phosphates
HA (Ca10(PO4)6(OH)2) and related calcium phosphate
(Bruder and Caplan 2000)-based ceramics (e.g. b-tricalcium
phosphate [b-TCP]) have been researched for biomedical
applications (Hench and Wilson 1999; Chai et al. 2012).
They have excellent biocompatibility due to their chemical
and structural similarity to the mineral phase of human
bones. These bioceramics are characterised by their bioac-
tivity, an ability to bond directly to the surrounding bone
tissue, and osteoconductivity, an ability to support osteo-
blastic cell attachment, proliferation and differentiation both
in vivo and in vitro studies (Boccaccini and Blaker 2005).
The principal disadvantage of the use of HA and related
calcium phosphates as bone scaffold is that the slow degra-
dation of these inorganic ceramics in the body limits their
utility for bone-regeneration applications. Clinical investi-
gation has shown that implanted HA and calcium phosphates
are virtually inert, remaining within the body for as long as
6–7 years post-implantation (Marcacci et al. 2007). Clinical
follow-up studies have demonstrated that there are no visible
signs of biomaterial resorption (Marcacci et al. 2007). The
dissolution rate of the HA and related calcium phosphates
can be ranked in the following order (Rezwan et al. 2006):
Amorphous CaP [ amorphous HA [ crystalline CaP
[ crystalline HA:
HA and related calcium phosphates also have unsatis-
factory mechanical properties. Compared with those of
human bone, the compressive strength values of HA and
related calcium phosphates are much higher; however, they
fail in tensile strength and fracture toughness (Table 4).
Therefore, the use of calcium phosphates alone is limited to
non-load-bearing sites despite their good biocompatibility
and osteoconductivity.
Bioactive glasses
The advantage of bioactive glasses over HA and related
CaP is their degradability (Chen et al. 2012; Hench 2006;













Calcium phosphates 20–900 30–200 30–103 \1.0
HA [400 *40 *100 *1.0
45S5 Bioglass *500 42 35 0.5–1
Cortical bone 130–180 50–151 12–18 6–8
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O’Donnell 2012; Jones 2013; Baino and Vitale-Brovarone
2011; Fu et al. 2011; Gerhardt and Boccaccini 2010). Many
compositions of bioactive glasses have been developed;
these can be grouped according to their chemistry: bioac-
tive silicate (SiO2) glasses, bioactive phosphate (P2O5)
glasses, and bioactive borate (B2O3) glasses (Jones 2013;
Baino and Vitale-Brovarone 2011). This section focuses on
the first category.
Bioactive silicate glass, such as 45S5 Bioglass, was
invented by Hench in 1969 (Hench 2006). The main
components of bioactive silicate glasses are SiO2–Na2O–
CaO–P2O5, having \55 % SiO2 in weight percentage.
Bioactive silicate glasses are recognised as Class A bio-
active materials because they offer high bioactivity
involving both osteoconduction and osteoproduction,
while HA is recognised as Class B bioactive material
because it exhibits only osteoconductivity (Chen et al.
2008). Bioactive silicate glasses are able to induce a
strong bond to bone tissue when implanted or exposed to
physiological body fluid. The formation of a carbonated
hydroxyapatite (HCA) layer on the surface of the glass
leads to bone bonding (Rezwan et al. 2006; Hench et al.
1971; Hench 1998, 1999). The bone-bonding mechanism
of bioactive glasses has been proposed by Hench, as
demonstrated in Fig. 1.
An added advantage of bioactive glasses is that ionic
dissolution products from the reactions on bioactive glas-
ses’ surfaces can induce intracellular and extracellular
response, stimulating new bone formation (osteogenesis)
(Xynos et al. 2001; Sun et al. 2007). There are also studies
showing that 45S5 Bioglass can enhance the secretion of
vascular endothelial growth factor (VEGF) and VEGF gene
expression in vitro, as well as vascularisation in vivo (Day
et al. 2004). Given all these remarkable advantages of 45S5
Bioglass, it makes a sense that 45S5 Bioglass has been
used in a number of commercial products for treatment of
bones, joints and teeth. For example, NovaMin (Glaxo-
SmithKline, United Kingdome) in the form of toothpaste
has been used to reduce tooth sensitivity. NovaBone
(Alachua, Florida) as a bone-filler material has been used
for the treatment of periodontal disease. The latter has also
exhibited good performance as an autograft in posterior
spinal fusion operations during a period of a 4-year follow-
up study, with fewer infections (Jones 2013).
While the application of bioactive glasses in biomedical
implants in the past 20 years has demonstrated their
excellent performance, the problems associated with their
high brittleness and low fracture toughness remain to be
addressed (Table 4). To overcome these problems, the
composites between bioactive glasses and polymers are
needed (Chen et al. 2008; Rezwan et al. 2006; Chen et al.
2012; Roether et al. 2002; Lu et al. 2003; Zhang et al. 2004).
A general issue with bioceramics is that mechanical
strength and biodegradability, which are two essential
requirements of bone tissue scaffolds, are antagonistic to
each other. Mechanically strong materials (e.g. crystalline
HA and related calcium phosphates) are virtually bioinert,
and biodegradable materials (e.g. bioactive glasses) tend to
be fragile. Sintering Na2O-containing bioactive glasses into
a mechanically capable glass ceramics or fully crystalline
ceramics has been proven to be a strategy to achieve
mechanical strength competence while retaining good
biodegradability in the material (Chen et al. 2006).
Biocomposites
To mimic natural bone, the composites of polymers and
ceramics (biocomposite materials) have been studied and
developed in an attempt to increase both the mechanical
and biological performances of the scaffolding materials
(Mano et al. 2004). Taking advantage of the polymers’
toughness and the ceramics’ strength, their composite
materials could have a satisfactory combination of both
properties. Moreover, the addition of bioactive ceramic
phases to polymer phases will not only counteract the poor
bioactivity of polymers, but also buffer the acidic degra-
dation products of polymers (Niemela¨ and Kelloma¨ki
2011; Shokrollahi et al. 2010).
11 Crystallisation of matrix
10 Generation of matrix
9 Differentiation of stem cells
8 Attachment of stem cells
7 Action of macrophages
6 Adsorption of biological moieties in HCA layer
5 Formation of crystalline HCA
4 Adsorption of amorphous Ca + PO4 + CO3
3 Polycondensation of SiOH + SiOH Si–O–Si
1&2 Formation of SiOH bonds
Surface of bioactive glass







Fig. 1 Sequence of interfacial
reactions involved in forming a
bond between bone and
bioactive ceramics and glasses
(O’Donnell 2012; Jones 2013;
Gerhardt and Boccaccini 2010)
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Polymer/calcium phosphate composites
For over three decades, calcium phosphate ceramics such
as HA and b-TCP have been used as bone substitutes.
However, their application alone is limited due to the dif-
ficulty in the fabrication of highly porous structures and
their mechanical brittleness. Polymer/calcium phosphate
composites fabricated by the addition of a calcium phos-
phate ceramic to the polymer have been demonstrated to
have good biocompatibility. Many reviews have been
published on the composites of HA or b-TCP and biode-
gradable polymers in terms of their in vitro and in vivo
performances as scaffolds in bone tissue engineering. The
study of Laurencin (Attawin et al. 1995; Laurencin et al.
1996; Devin et al. 1996) demonstrated that porous scaf-
folds made from a PLGA/HA composite enhanced cell
proliferation and differentiation, as well as bone mineral
formation, compared with the PLGA group. Cao and Ku-
boyama (2010) reported that PGA/b-TCP composite
showed a better osteoconductivity and enhanced new bone
formation within 90 days during the repair of critical-sized
bone defects in rat femoral medial-epicondyles compared
with PGA/HA composite and implant-free controls.
Polymer/bioglass composites
In the past two decades, a great deal of progress has been
made with bioactive glass/polymer composites. Silicate
bioactive glasses are thought to have a future in bone tissue
engineering because they exert a genetic control regulation
over the osteoblast cycle and rapid expression of genes.
Silicon has been found to have an effect on bone minerali-
sation and gene activation (Xynos et al. 2001; Sun et al. 2007;
Day et al. 2004). There has been a great deal of research
published on this subject. For example, PLA and bioactive
glass composites have been developed. It has been found that
the composites could exhibit the formation of calcium
phosphate layers on their surfaces and support rapid and
abundant growth of human osteoblasts and osteoblast-like
cells during in vitro test (Zhang et al. 2004; Blaker et al. 2003,
2005; Boccaaccini et al. 2003; Li and Chang 2004; Lu et al.
2003; Maquet et al. 2003; Maquet et al. 2004; Navarro et al.
2004; Stamboulis et al. 2002; Verrier et al. 2004). Addi-
tionally, biodegradable polymer-coated porous Bioglass
composite scaffolds exhibited enhanced strength compared
with the bared ceramic scaffolds (Blaker et al. 2005; Chen
and Boccaccini 2006; Bretcanu et al. 2007, 2009; Bretcanu
and Boccaccini 2012; Metze et al. 2013).
The compressive modulus of a composite scaffold
depends not only on the porosity and pore size of the
composite scaffold, but also on the content of the ceramic
or glass added. It must be mentioned that only a few
composite scaffolds presented in Table 5 were found to
have the modulus that could reach in the range of the
modulus of the cancellous bone. Hence, further develop-
ment and selection of scaffolding biomaterials for hard
tissue support are needed.
Summary of scaffolding biomaterials
The ideal biomaterial used for tissue engineering should be
mechanical capable, bioresorbable, biocompatible and
supportive to cell attachment, proliferation and differenti-
ation. In addition, it should degrade at a physiologically
relevant rate. This goal has not yet been achieved. To design
a new composite scaffold, it is necessary to weigh up the
advantages and disadvantages of the potential biomaterials.
A comparison of all scaffolding biomaterials (polymeric
materials, bioceramics and biocomposites) is provided in
Table 6. Among polymeric materials, amorphous PDLLA
is one of the most interesting scaffolding polymers as a
coating material in orthopaedic applications because it
shows excellent biocompatibility in vivo, good osteocon-
ductivity and high mechanical stability (Schmidmaier et al.
Table 5 Porous composites
scaffold designed for bone
tissue engineering (Chen et al.
2008; Rezwan et al. 2006)
Scaffold composite Percentage of
ceramic (wt %)
Porosity (%) Pore size (lm) Modulus (MPa)
Ceramic Polymer
Amorphous CaP PLGA 28–75 75 [100 65
HA PLLA 50 85–96 100 9 300 10–14
PLGA 60–75 81–91 800–1,800 2–7.5
PLGA 30–40 110–150 337–1,459
Bioglass PLGA 75 43 89 51
PLLA 20–50 77–80 *100 137–260
*10
PLGA 0.1–1 50–300
PDLLA 5–29 94 *100
10–50
Cancellous bone 100–500 100–500
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2001a, b; Gollwitzer et al. 2005). Moreover, low-molecular
weight PDLLA coating can be used to deliver drugs such as
growth factors, antibiotics or thrombin inhibitors
(Schmidmaier et al. 2001; Gollwitzer et al. 2003). Cross-
linked synthetic polyester elastomer, particularly PGS, has
also attracted a great deal of attention for use as scaffolding
biomaterials because it is able to provide mechanical sta-
bility and structural integrity to tissues or organs without
mechanical irritation to the host tissues or organs. Impor-
tantly, it has the potential to be tailored in the degradation
rates to match clinical requirements.
Among the bioactive ceramics and glasses shown in
Table 6, bioactive silicate glasses offer great opportunities
to enhance vascularisation, exert the rapid expression of
genes, and tailor their degradation rate. The controllable
biodegradability of bioactive glasses makes them advan-
tageous over HA and related CaP. For these reasons, 45S5
bioactive glass is the material of choice for this project.
Although bioactive glasses are brittle with low fracture
toughness (Table 4), the composites of these materials with
polymers can alleviate these disadvantages.
Scaffolding techniques
Design parameters of scaffolds for bone engineering
scaffolds
In an organ, cells and their ECM are usually organised into
3D tissues. Therefore, in tissue engineering, a highly por-
ous 3D matrix (scaffold) is often necessary to accommo-
date cells and to guide their growth and tissue regeneration
in three dimensions. The structure of bone tissue varies
with its location in the body. Hence, the selection of con-
figurations, as well as appropriate biomaterials, will depend
on the anatomic site for regeneration, the mechanical loads
present at the site, and the desired rate of incorporation.
First, the matrix should have a high porosity and a proper
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pore size to support cell migration, new tissue deposition,
and nutrient delivery. Second, the anatomically shaped
matrix should be designed to guide new bone formation.
Third, the rate of degradation should match the healing rate
of the new tissue, should be neither too fast nor too slow
(probably 6 months for in vivo applications) (Temenoff
et al. 2000). The most important parameters of bone-scaf-
fold design are listed in Table 7.
Conventional fabrication techniques of bone scaffolds
Numerous methods have been developed and employed to
fabricate 3D scaffolds for tissue engineering applications;
these can be divided into two principal categories: con-
ventional fabrication techniques (Murphy and Mikos 2007;
Morsi et al. 2008; Chen 2011) and solid freeform (SFF)
techniques. The latter is also termed ‘rapid prototyping’
(RP) (Chu 2006; Bartolo et al. 2008; Hopkinson and
Dickens 2006; Melchels et al. 2012). Each of these tech-
niques produces different features and characteristics of
internal architecture, such as pore size, pore structure and
interconnectivity, as well as mechanical properties.
Therefore, a selection of technology for the scaffold fab-
rication needs to be made based on a holistic review and
comparison of all relevant techniques. This section pro-
vides a review on eight conventional approaches that are
widely used for producing bone scaffolds (Fig. 2). Com-
puter-aided manufacturing (Andrade et al. 2002) technol-
ogies will be reviewed separately in ‘‘Solid freeform
fabrication (SFF) Techniques’’.
Solvent casting
Solvent casting involves dissolution of the polymer-ceramic
particle mixture in an organic solvent, and casting the solu-
tion into a predefined 3D mould. The solvent subsequently
evaporates, leaving a scaffold behind. The advantage of this
Table 7 Scaffold design parameters for bone tissue engineering
application (Temenoff et al. 2000)
Parameters Requirement
Porosity Maximum without compromising mechanical
properties significantly
Pore size 300–500 lm
Pore structure Highly interconnected
Mechanical properties




















Bulk or surface erosion
Biocompatibility No chronic inflammation
Sterilisability Sterilisable without altering material properties
Fig. 2 Schematic presentation of commonly used techniques for scaffold fabrication: a solvent casting/particulate leaching; b freeze-drying;
c TIPS; d gas foaming and supercritical fluid processing; and e electrospinning (Puppi et al. 2010)
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method is that the preparation process is easy and does not
require expensive equipment. However, there are two major
disadvantages. First, this approach can only form scaffolds of
simple shapes (flat sheets and tubes). Second, the residual
solvents left in the scaffold material could denature proteins,
and thus be harmful to cells and biological tissues.
Solvent casting/particulate leaching
This approach involves casting a mixture of polymer
solution and porogen particles such as sieved salt or sugar
particles, and inorganic granules to fabricate porous
membranes or 3D networks (Cao and Kuboyama 2010;
Guan and Davies 2004; Hayati et al. 2011). The size of
porogen particles and the ratio of polymer to porogen
directly control the internal pore size and porosity of the
final scaffold, respectively. After solvent evaporation, the
dried scaffolds are fractionated in water or a suitable sol-
vent to remove particulates. Once the porogen particles
have been completely leached out of the mixture, a porous
structure is obtained. This method has both advantages and
disadvantages similar to the solvent casting technique.
Freeze-drying
This method also requires the use of organic solvents or
water to produce a porous scaffold but does not require the
use of porogen particles. First, a synthetic polymer is dis-
solved into a suitable solvent. Subsequently, the solution is
poured into moulds of specified dimensions and frozen with
liquid nitrogen. The frozen polymer is lyophilised to pro-
duce porous scaffolds of highly interconnected pores with
porosities being up to 90 %. One of the great benefits of this
technique is the ability to fabricate a scaffold without the use
of a high temperature. Further, the pore size and the mor-
phology of the scaffolds depend on specific processing
parameters, including the freezing rate, temperature and
polymer concentrations. However, sponge scaffolds pro-
duced by this technique exhibit a porous structure of irreg-
ular and small pore size, typically ranging from 15 to 35 lm.
TIPS
This approach involves the use of a volatile organic solvent
of a low melting point to dissolve the polymer mixed with/
without ceramic particles. To induce phase separation, the
polymer solution is first cooled rapidly. This leads to the
solidification of solvent, which forces the polymer solute
into the interstitial spaces. Subsequently, a porous scaffold
is obtained after the evaporation of solvent via sublimation.
A control of the large number of variables, including types
of polymer and solvent, polymer concentration and phase
separation temperature allows the generation of a variety of
scaffold architectures (Nam and Park 1999; Molladavoodi
et al. 2013). The principal advantage of this method is that
a high porosity can be achieved by adjusting the parame-
ters. It has been shown that the use of thermally induced
phase separation (TIPS) followed by freeze-drying can
produce scaffolds of a porosity [95 %. Varying the prep-
aration conditions can also tailor the pore morphologies of
scaffolds (Yin et al. 2003; Kim et al. 2004; Barroca et al.
2010). However, the pore size of scaffolds produced by this
technique is typically \200 lm (Hutmacher 2000), which
limits its utility in bone tissue engineering.
Gas foaming/supercritical fluid processing
The high-pressure gas-foaming technique employs a gas as
a porogen to create interconnected pores. It was developed
to eliminate the use of organic solvents, the residual of
which might result in an inflammatory response after
implantation. This fabrication process can be conducted at
mild conditions. CO2, a non-toxic and non-flammable gas,
has been widely used in supercritical fluid processing. First,
a polymer is placed in a chamber and then saturated with
high-pressure CO2. As the pressure is rapidly dropped, the
nucleation and formation of pores occur as a result of the
thermodynamic instability in the gas/polymer system
(Mooney et al. 1996). The fabrication parameters such as
temperature, pressure, degree of saturate and depressuri-
sation time have a great influence on the pore morphology
and pore size of the scaffolds. The gas-foaming technique
typically produces a sponge-like structure with the average
pore size in the range of 30–700 lm and a porosity up to
85 % (Chen 2011). The drawbacks of this process include
the use of the excessive heat during compression moulding;
closed, non-interconnected pore structures, and a non-
porous skin layer at the surface of the final product.
To achieve a highly interconnected network, a combi-
nation of high-pressure gas foaming and particulate
leaching techniques is developed. Using this combinatory
technique, Harris et al. (1998) have produced PGLA
scaffolds of various porosity by adjusting the salt/polymer
ratio and salt particle size. The overall porosity of their
products was improved up to 97 %.
Textile technology (electrospinning)
Electrospinning is a versatile process that involves the use
of an electrical charge to create non-woven scaffolds from
a polymer solution. This technique allows the fabrication of
various fibre patterns with a higher porosity. A number of
variables, including solution viscosity, polymer charge
density, polymer molecular weight and electric field
strength, can be adjusted to control the fibre diameter and
morphology (Pham et al. 2006). To date, the
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electrospinning technique has been widely used to fabricate
scaffolds for tissue regeneration applications because it
possesses great advantages, including producing fibres with
diameters from few microns down to the nanometre range,
and highly porous scaffolds with interconnected pores. The
disadvantage of this technique is that it involves the use of
organic solvents, which could be toxic to cells if not
completely removed (Mikos and Temenoff 2000).
Powder-forming processes
The powder-forming process (Fig. 3) was developed for
the fabrication of porous ceramic and glass scaffolds. In
this process, a suspension of ceramic particles in a suitable
liquid (such as water or ethanol) called slurry is used to
prepare green bodies. Fillers such as sucrose, gelatine,
PMMA microbeads and a wetting agent (i.e. a surfactant)
are added into the ceramic suspension, and these chemicals
will produce porosity when they are evaporated or burned
out during sintering (Chen 2011). In addition, the presence
of binders such as polysaccharides (Haugen et al. 2004),
poly(vinyl alcohol) (PVA) (Andrade et al. 2002), and
poly(vinyl butyl) (PVB) (Kim et al. 2003) in slurries plays
an important role in improving the strength of the green
body before the product is sintered (Reed 1988).
The methods for forming green bodies can be classified
as dry and wet processes (Ishizaki et al. 1998), as listed in
Table 8. Depending on the preparation procedure, each
type of method provides a unique geometric shape of
ceramic products and porous structure in ceramic.
Among these processes, the replication technique, also
named the ‘polymer-sponge’ method (Fig. 4), has gained
considerable attention, as it offers the potential of forming
uniform dispersion of ceramic powder within a template,
resulting in controllable pore size, high porosity and in-
terconnectivity in scaffolds. For this reason, this review
highlights the replication technique. In this process, a
polymer foam with the desired macrostructure (e.g. poly-
urethane) is immersed in a ceramic slurry to prepare the
green bodies of ceramic foams. After drying, ceramic-
coated polymer foam is subsequently heated to decompose
the polymer foam, and then the ceramic is sintered to the
desired density. Using this technique, Chen et al. (2006)
have produced a porous 45S5 Bioglass scaffold with
porosity of *90 % and pore size ranging from 510 to
720 lm. The sintering conditions have also been optimised
to achieve much improved mechanical stability in Bio-
glass scaffolds with good bioactivity maintained. In
subsequent work, Chen and Boccaccini (2006) successfully
toughened their fabricated 45S5 Bioglass foams by
applying a PDLLA coating.
Start with a ceramic powder
Prepare slurry from the powder
Form a green body from the slurry 
Heat treatment of the green body to burn out the 
organic additives and sinter the ceramic structure
End with a porous ceramic
Additive 
(e.g. porogen, binder)
Fig. 3 Flowchart of the powder sintering method to produce a porous
ceramic scaffold (Chen 2011)














(Fukasawa et al. 2001)
6. Polymer-
replication
(Chen et al. 2006; Schwartzalder and Somers
1963; Chen et al. 2008; Fu et al. 2008; Liu
et al. 2009)
7. Gel-casting (Ramay and Zhang 2003; Potoczek et al.
2009; Wu et al. 2011; Tulliani et al. 2013)
Ceramic (or glass) powder
Prepare slurry from the powder
Coat a polymer foam with the slurry
Dry, burn out the polymer substrate and sinter the green body
Ceramic (or glass) foam
Binder
Add
Fig. 4 Flowchart of fabrication of ceramic or glass foams via
polymer foam replication (Chen 2011)
Prog Biomater (2014) 3:61–102 71
123
Sol–gel techniques
Sol–gel is a versatile process, involving forming a sol by
the addition of a surfactant, followed by condensation and
gelation reactions (Fig. 5). This technique is based on the
chemical reaction of inorganic polymerisation of metal
alkoxides. Using the sol–gel process, it is possible to
fabricate ceramic or glass materials in a variety of forms,
including ultra-fine or spherical-shaped powders, thin-film
coatings, ceramic fibres, microporous inorganic mem-
branes, monolithic ceramics and glasses, and highly por-
ous aerogel materials (Chen 2011; Raucci et al. 2010;
Chen et al. 2010, 2012; Chen and Thouas 2011; Sepulv-
eda et al. 2002). Despite its advantages, the sol–gel
technique does not produce porous ceramics of high
mechanical strength. Very recently, the research team led
by Chen et al. (2010) successfully developed a sol–gel
process of Na2O-containing bioactive glass ceramics,
which was reported to have improved mechanical strength
without losing a satisfactory biodegradability. However,
the mechanical properties of the sol–gel-derived 45S5
Bioglass ceramic scaffolds are not as the same as those
of bone.
Limitation of conventional fabrication techniques
Ideally, the scaffold for bone tissue engineering should be
porous with appropriate pore size and high interconnec-
tivity to encourage cell penetration, tissue ingrowth and
rapid vascular invasion, as well as nutrients delivery. It
should also be designed to provide proper mechanical
integrity and degrade later at a rate to match the healing
kinetics of injured bone. Although the conventional fab-
rication techniques that have been described have pro-
duced scaffolds used in tissue engineering of various
types, most of them are incapable of producing fully
continuous interconnectivity and uniform pore morphol-
ogy within a scaffold. Additionally, the pore size, pore
geometry and spatial distribution cannot be precisely
controlled in these conventional processes. Some con-
ventional techniques are manual-based, with poor repro-
ducibility. Another limitation of most conventional
fabrication methods is the need of an organic solvent to
dissolve polymers and other chemicals, as well as the use
of porogens to create pore structures. Most solvents and
porogens are toxic, and their residues in the scaffold may
cause severe inflammatory responses. Figure 6 shows the
porous morphologies produced by each of these conven-
tional fabrication techniques, and Table 9 provides the
details on average pore size, porosity and architecture of
the scaffolds produced by these techniques (Hutmacher
2000; Leong et al. 2003).
Solid freeform fabrication (SFF) techniques
Overview of SFF techniques
Fabricating a satisfactory biomimetic bone substitute is still
a challenge in the field of bone tissue engineering. To
control precisely the porous architecture of the scaffold,
various SFF techniques, also known as RP, have been
developed. In essence, this technology is based on a
computer-aided design (CAD) to fabricate custom-made
devices directly from computer data. In these techniques,
complex scaffold architecture is manufactured in a layer-
by-layer manner that builds via the processing of solid
sheet, liquid or powder materials stocks according to its
computerised cross-sectional 3D image. Unlike the con-
ventional techniques described in ‘‘Conventional fabrica-
tion techniques of bone scaffolds’’, SFF techniques have
significant advantages over those conventional techniques
in terms of consistency, reproducibility of designed scaf-
folds and the capabilities of precise control over the
architecture of 3D scaffolds such as internal structure,
geometry, pore sizes and spatial distribution so that both
biological and mechanical performances of tissue-engi-
neered constructs can be improved (Leong et al. 2003;
Yeong et al. 2004; Hutmacher et al. 2004).
The brief definitions of technical terms used in the SFF
techniques described by Grimm (Grimm, 2004) are listed
in alphabetical order as follows:
1. two dimensional (2D): the term indicates that the
resulting file is a flat representation with dimensions
in only the X and Y axes
2. 3D: abbreviation for three dimensional—the term
indicates that the resulting file is a volumetric
representation with dimensions in the X, Y, and Z axes
Alkoxides: TEOS and TEP
Prepare a sol from the alkoxides and 
Ca(NO3)2 in deionised water solvent
When the gelation of the foamed sol is 
nearly completed, cast the gel in moulds
Foam the sol by vigorous agitation
Age, dry and sinter the gel
Catalysis (HNO3) to 
speed up hydrolysis
Surfactant for foaming, 




Fig. 5 Flowchart of the production of bioactive glass foams using
sol–gel process (Chen 2011)
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3. accuracy: the difference between an intended final
dimension and the actual dimension as determined by
a physical measurement of the part in addition to those
for linear dimensions, there are accuracy specifica-
tions for such features as hole sizes and flatness
4. CAD: a software program for the design and docu-
mentation of products in either 2D or 3D space
5. CAM: a software program that uses the design data of
CAD to build tool paths and similar manufacturing
data for the purposes of machining prototypes, parts,
fixtures, or tooling
6. facet: a polygonal element that represents the smallest
unit of a 3D mesh
7. feature: discrete attributes of a model or prototype
that include intrinsic geometric parameters (i.e.
length, width, depth, holes, slots, ribs, bosses,
snap fits) and other basic elements of a product
design. Figure 7 presents an example of designed
unit cell architectures based on different feature
primitives.
8. layer thickness: the vertical dimension of a single
slice of a stereolithography (SLA) file
9. minimum feature size: the smallest detail of an object
that can faithfully be reproduced
10. part finish: a qualitative term for the appearance of a
part
Fig. 6 Typical pore morphologies of porous scaffolds by various
techniques: a solvent casting/particulate leaching (Dalton et al. 2009);
b freeze-drying (Morsi et al. 2008); c TIPS (Dalton et al. 2009); d gas
foaming (Morsi et al. 2008); e electrospinning (Dalton et al. 2009);
f replication technique (Chen et al. 2008); g sol–gel technique
(Sepulveda et al. 2002)
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11. primitive: simple geometric shapes of a solid model,
such as a cube, cylinder, sphere, cone, or pyramid
12. resolution: the minimum increment in dimensions that
a system achieves—it is one of the principal deter-
mining factors for finish, appearance and accuracy
(but certainly not the only one)
13. road, road width, gap width and raster angle: the
terms, ‘road’, ‘road width’ and ‘gap width’ are
applied to the fused deposition modelling (FDM)
process—an illustration of road (many deposited lines
of material), road width (diameter of the circular
cross-section of the road [measured in X–Y plane]),
gap width (space between roads), raster angle (direc-
tion of deposited road) is provided in Fig. 8.
14. STL: a neutral file format exported from CAD
systems for use as input to RP equipment—the file
Fig. 7 The designed scaffold unit cells based on different feature primitives (Sun et al. 2007)
Table 9 Summary of advantages and disadvantages of each conventional technique commonly used in scaffold fabrication (Chen 2011;










30–300 20–50 Spherical pores Simple method; controlled porosity and
pore size
Possibility of residual of solvent
and salt particles; structures
generally isotropic; insufficient
mechanical integrity for use in
load-bearing application
Freeze-drying 15–35 [90 High volume of
interconnected
micropores
Pore structure with high
interconnectivity; good porosity
Insufficient mechanical integrity
for use in load-bearing
application; small pore sizes
Thermally induced
phase separation
5–600 \90 High volume of
interconnected
micropores
Simple method; high porosities; pore
structure with high interconnectivity;
controllable structure and pore size by
varying preparation conditions
Long time to sublime solvent;
possibility of solvent residual;









Free of toxic solvents; control of
porosity
Insufficient mechanical integrity
for use in load-bearing
application; inadequate pore
interconnectivity; possibility of
closed pore structure; formation
of an outer skin
Textile technology
(electrospinning)
\1–10 90 Simple method; high interconnected
porosity; high surface area to volume
ratio
Insufficient mechanical integrity
for use in load-bearing
application; possibility of solvent






300–700 [80 High volume of
interconnected
micropores
Simple method; porous structure similar
to sponge bone; highly porous and with
open pores; free of toxic chemicals
Insufficient mechanical integrity




[600 [70 High surface area; microstructure similar
to that of dry human trabecular bone
Insufficient mechanical integrity
for use in load-bearing
application; possibility of solvent
residual
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contains point data for the vertices of the triangular
facets that combine to approximate the shape of an
object
15. slice: a single layer of an SLA file that becomes the
working surface for the additive process
16. support structure: a scaffold of sacrificial material
upon which overhanging geometry is built—it is also
used to attach rigidly the prototype to the platform;
after prototype construction, it is removed in a post-
processing operation
17. voxel: a shortened term for volume cell.
The technological flowchart of all RP techniques is
illustrated in Fig. 9.
Among a number of SFF techniques, SLA, selective
laser sintering (SLS), laminated object manufacturing
(LOMTM), ink-jet printing technologies [i.e. 3D printing
(3DP)], and FDM are most widely used for the construction
of tissue engineering scaffolds. SFF offers a number of
great benefits, which are summarised below (Leong et al.
2003):
1. Customised design: using CAD modelling, SFF tech-
niques can manufacture complex scaffolds based
on patient-specific data from a medical imaging
technique.
2. Computer-controlled fabrication: SFF techniques are
able to fabricate scaffolds of highly accurate and
consistent pore morphology, using a minimum labour.
High porosity (up to 90 %) and full interconnectivity
can easily be achieved. These techniques can also
reproduce highly complex architectures in a relatively
short time without using a mould.
3. Anisotropic scaffold microstructures: SFF techniques
can produce macroscopic and microscopic structural
features in different regions of the same scaffold; this
could lead to the hierarchical structures of multiple cell
types (Crouch et al. 2009). With an SFF technique, it is
easy to fabricate a functionally graded scaffold (FGS)
that has different mechanical properties at different
areas of the same scaffold (Chua et al. 2011; Hutm-
acher et al. 2004).
4. Processing conditions: SFF techniques are flexible
because they work under a diverse range of processing
conditions, including solvent-free and/or porogen-free
processes and mild temperature.
The remainder of this review will focus on the four most
frequently used techniques (i.e. SLA, SLS, 3DP and FDM)
in the field of tissue engineering.
SLA
Principle of SLA
SLA, the oldest of the SFF technologies, was developed by
3D Systems in 1986. It has since been widely used in the
field of biomedical engineering. The system of SLA, as
demonstrated in Fig. 10, consists of a tank of photo-sen-
sitive liquid resin, a moveable built platform, an ultraviolet
(UV) laser to irradiate the resin, and a dynamic mirror
system. The SLA process employs a UV laser to build a
photo-sensitive liquid resin material layer-by-layer into a
3D scaffold. Once one layer is completely solidified onto a






Fig. 8 Cross-sectional structure
viewed in the X–Z plane and
direction of the FDM-build part
(Zein et al. 2002)
Medical imaging
(e.g. CT, MRI)
3D solid model creation in CAD
(pro/engineer [PTC])
SFF system computer
(e.g. generation of slice data) 
SFF fabrication
(e.g. SLA, SLS, FDM) 
Post processing





Fig. 9 Flowchart presenting typical CAM technology (Leong et al.
2003)
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distance into the resin-filled vat. Subsequently, an amount
of liquid resin covers the previous layer, forming the next
layer. These steps are repeated until a complete 3D part is
formed. Finally, uncured resin is washed off and the
scaffold is post-cured under UV light, yielding a fully
cured part (Chu 2006; Bartolo et al. 2008; Hopkinson and
Dickens 2006).
SLA-produced scaffolds used in tissue engineering
SLA can fabricate 3D scaffolds from polymers, bioce-
ramics and composites. The spatial resolution is usually
approximately 50 lm. SLA has been applied to biode-
gradable polymers, such as poly(propylene fumarate)
(PPF) (Cooke et al. 2002; Lee et al. 2007), photocros-
slinkable PCL (Elomaa et al. 2011), PDLLA (Melchels
et al. 2009; Jansen et al. 2009) (Fig. 11), vinyl esters
(Heller et al. 2009) and photocrosslinkable poly(ester
anhydride) (Seppala et al. 2011), to create well-defined
scaffolds with interconnected porosity of 70–90 %. Using
SLA, Lee et al. (2007) have successfully fabricated highly
complex bone scaffolds from PPF and diethyl fumarate
(Shuai et al. 2013) resins. In another study, Elomaa et al.
(2011) fabricated PCL scaffolds using SLA, showing a
highly porous interconnected network with porosity of
70 %, and pore size of 465 lm, with no observable
material shrinkage.
The SLA system can also fabricate hydrogel polymer
scaffolds. The main difficulty in scaffold fabrication using
hydrogel is the development of water-soluble components
that are functional and photo-labile (Fisher et al. 2001). Seck
et al. (2010) have produced 3D biodegradable hydrogel
scaffolds from an aqueous photo-sensitive resin-based
methacrylate-functionalised poly(ethylene glycol) (PEG)/
PDLLA macromers, using the SLA process. Their scaffolds
have a well-defined porous network structure, narrow pore
size distribution, and highly interconnected pores.
The research team of Arcaute et al. (2010) has devel-
oped 3D PEG-based multi-material scaffolds using SLA.
The scaffold is aimed at the micro-scale characteristics that
could build a cellular microenvironment with a spatially
controlled bioactivity. However, the scaffold is deemed of
little use for tissue engineering applications due to the poor
shape of the fabricated samples.
SLA is also used to build a ceramic network using a
photo-sensitive polymer as a binder. The use of SLA to
fabricate bioceramic scaffolds was first explored by Chu
et al. (1996, 1997, 2002). A suspension of HA and a low
viscosity acrylate resin was printed to form scaffolds, and
the resin was subsequently burned out, leaving behind a
ceramic scaffold of 50 % porosity. However, to print cera-
mic-based scaffolds, a ceramic suspension should have a
solid content in the range of 20–50 volume percentage in the
resin (Stuecker et al. 2003). However, the ceramic suspen-
sion at this content level has a very high viscosity, which
introduces difficulties to SLA processing. Some researchers
have developed an indirect fabrication process to produce
bioceramic scaffolds from calcium phosphate (Hollister
2005) and Bioglass (Padilla et al. 2006; Li et al. 2013) by
combining SLA and the casting method. In this indirect
process, an epoxy mould is first created by SLA, and then a
suspension of ceramic acrylate is cast into the mould. When
Fig. 10 Schematic representation of an SLA system (Chu 2006;
Bartolo et al. 2008; Hopkinson and Dickens 2006)
Fig. 11 Images of PDLLA
scaffolds built by SLA.
a Photograph; and b SEM
micrograph (scale bars
represent 500 lm) (Melchels
et al. 2009)
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the mould is removed by thermal treatment, the 3D scaffold
with the inverse shape of the mould is obtained.
SLA has also been used for the fabrication of polymer/
ceramic composite scaffold. It is often more difficult to
process a composite than a polymer due to the high vis-
cosity of polymer/ceramic suspension, which is a result of
the addition of the ceramic powder (Melchels et al. 2010).
Therefore, SLA has not been used widely for fabricate
polymer/ceramic composite scaffolds. Using SLA, Elomaa
et al. (2013) successfully produced bioactive glass/meth-
acrylated PCL composite scaffolds with well-defined
porosity. The scaffolds were reported to show no unwanted
polymer layer covering the Bioglass particles and were
thus able to enhance the attachment and proliferation of
human fibroblast.
Advanced SLA technology
With the reduction in the laser power and improvement of
both lateral and vertical resolutions, new generations of
SLA technology have emerged. There are three new
technologies micro-stereolithography (lSLA), two-photon
polymerisation (TPP), and digital light processing (DLP).
lSLA lSLA has been developed for the fabrication of 3D
microstructures in a better resolution. This process employs
a single photon beam that can be focused more precisely
with a reduced spot size of laser. lSLA fabricates complex
3D micro-scale structures with a layer thickness of less
than 10 lm. In a PPF scaffold fabricated by the lSLA
process (Lee et al. 2008), the rectangular pore sizes are
250–260 lm, and pores are interconnected in the three
dominant directions. The mechanical properties of the PPE
scaffold were similar to those of human trabecular bone.
Similar work was also reported by Choi et al. (2009), who
produced PPF-based 3D scaffolds with interconnected
pores of 100 lm in size using a scanning lSLA system.
Although there are limitations associated with material
shrinkage, overcure of the downward surface and the
inability to remove uncured resin, this system plays a role
in producing 3D micro-scaffolds for tissue engineering.
lSLA has also been used to produce robust ceramic
scaffolds from HA and tricalcium phosphate (TCP)
(Fig. 12a) by Seol et al. (2013). A slurry was prepared from
a HA/TCP powder and photo-curable resin at 20 % vol-
ume, and was printed to build a designed 3D structure. The
green body was then sintered to remove the resin. The 3D
HA/TCP scaffolds have completely interconnected pore
sizing around 300 lm. The compressive strength of the
above ceramic scaffolds is in the range of human cancel-
lous bone, and the scaffolds are reported to support cell
proliferation and osteogenic differentiation.
TPP The development of a TPP system is aimed at fab-
ricating scaffolds at a greater depth, higher resolution up to
nanolevel, and an ultra-fast speed. In TPP, when a near-
infrared ultra-short-pulsed laser is closely focused into a
volume of photo-curable resins, real 3D microstructures
can be fabricated using a layer-by-layer accumulating
technique, making it a promising technique for 3D nano/
microfabrication. In addition, a spatial resolution of sub-
100 nm scale has been achieved with TPP by employing a
radical quenching mechanism (Melchels et al. 2010; Lee
et al. 2008). Using the TPP system, Weiss et al. (2009)
produced the first 3D micro-architectures and nano-archi-
tectures for cartilage-tissue engineering with a spatial res-
olution lower than 1 lm. In in vitro investigation using
bovine chondrocytes, TPP-structured scaffolds (Fig. 12b)
also showed high cytocompatibility as reported by the
same group (Weiss et al. 2011).
DLP DLP employs visible blue light. It was based on
lithography-based additive manufacturing technologies
(AMT), for building ceramic or glass parts. In the DLP
Fig. 12 Examples of bioceramics scaffolds built by advanced SLA: structures prepared from a HA and TCP using lSLA system (Seol et al.
2013); b methacrylated oligolactones using a TPP system (Weiss et al. 2011); and c 45S5 Bioglass using DLP system (Tesavibul et al. 2012)
Prog Biomater (2014) 3:61–102 77
123
process, dynamic masks are used to cure a whole layer at a
time. Hence, this technique offers a significantly higher
building speed. Other advantages of DLP include a high
lateral resolution of 40 lm (*50 lm of conventional
SLA), an efficient process for filling a large amount of
ceramic particles (*40–60 % solid loading), and no need
for expensive specialised equipment such as a laser or a
heating chamber (Felzmann et al. 2012). Using the DLP-
based process, Felzmann et al. (2012) have produced
ceramic scaffolds from 45S5 Bioglass, b-TCP or alumina.
Their scaffolds show interconnected pores of 300 lm in
size. After sintering, few microcracks were observed in the
scaffold material and shrinkage was 20 %. The same group
(Tesavibul et al. 2012) also use this technique to fabricate a
Bioglass based porous network (Fig. 12c) as an ortho-
paedic implant for the maxillofacial area.
Advantages and disadvantages of the SLA process
SLA technology is a versatile process that allows the
freedom of designing structures, the ability to build parts of
various sizes from submicron to decimetre, and a good
surface finish. Compared with other SFF techniques, SLA
shows excellent reproducibility, producing nearly identical
built architectures. This indicates the very high accuracy
and resolution of this technique (Heller et al. 2009; Mel-
chels et al. 2010). The porous network architecture pro-
duced by SLA is characterised by a much more
homogeneous cell distribution compared with that pro-
duced by the salt-leaching technique, and allowing more
efficient supply of oxygen and nutrients during cell cul-
turing (Melchels et al. 2010).
Nonetheless, the use of photo-sensitive material is pri-
marily considered a limitation of this process. Another
disadvantage of this process is associated with the shrink-
age of the polymer due to polymerisation. Toxicity such as
skin irritation and cytotoxicity caused by photo-sensitive
resins also appears to be a major problem. Most recently,
resins based on vinyl esters, an alternative resin that pos-
sesses better biocompatibility in vivo, have been explored
(Heller et al. 2009).
SLS
Principle of SLS
The SLS technique was developed at the University of
Texas in Austin in 1986 and was commercialised by DTM
Corporation in 1992. It employs a CO2 laser beam to fuse
(or sinter) selected regions of material powders onto a
powder bed surface, forming a material layer. Once a first
layer is solidified, the powder bed is lowered by one-layer
thickness. The next layer of the material is laid down on the
top of the bed by a roller. The process is repeated until the
part is completed. The solid powder acts as a structural
support, and the residual powder of the sample is removed.
An illustration of SLS is shown in Fig. 13 (Chu 2006;
Bartolo et al. 2008; Hopkinson and Dickens 2006).
SLS scaffolds for tissue engineering
SLS has been used to produce tissue-engineered constructs
from polymers, metals and ceramics, especially from bio-
degradable polymers (Williams et al. 2005; Yeong et al.
Fig. 13 Schematic
representation of the SLS
system (Chu 2006; Bartolo et al.
2008; Hopkinson and Dickens
2006)
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2010; Eshraghi and Das 2010; Pereira et al. 2012). Using
the SLS technique, Eshraghi and Das (2010) have produced
PCL scaffolds with orthogonal porous channels for
implants at load-bearing sites. Under optimal fabrication
conditions, the PCL scaffold demonstrated accurate
dimensions (within 3–8 %) compared with the designed
dimensions, nearly full density ([95 %) in the solid struts,
and remarkable compressive strength, which is the highest
compared with other scaffolds produced by SLS. In another
work, P3HB porous network produced by Pereira et al.
(2012) with SLS showed accurate geometrical and
dimensional features, nearly identical to the virtual model.
Fabricating bioceramic with the SLS technique directly
has proven difficult, primarily due to the fast heating and
cooling rates associated with the high-energy laser used
(Kruth et al. 2003; Lorrison et al. 2005; Cruz et al. 2005).
However, an indirect SLS method seems likely to be more
feasible for the fabrication of porous scaffolds as reported
by Lee et al. (2004; Lee and Barlow 1993; Goodridge
2004). In their studies, bioceramic powder particles were
coated with a polymer binder. During the SLS process, the
binder layer was melted, and the powder particles were
bonded together. In the subsequent sintering process, the
binder was burned off and bioceramics were sintered. The
scaffolds produced by the SLS technique demonstrated
good surface qualities and structural integrity, with flexural
strengths at 16 MPa, which is in the range of those of
cancellous bone (Goodridge et al. 2007).
In the SLS process, the particle size of the feedstock
powder and the content of binder have a critical influence
on the mechanical properties of the final scaffold product.
In their systematic studies, Kolan et al. (2012) tested the
effects of different particle sizes of the feedstock powder
and binder content on the quality of bioactive glass porous
scaffolds. The compressive strength values of their bioac-
tive glass products range from 41 MPa for a scaffold to
157 MPa for a dense part. The compressive strength of
bioactive glass scaffolds decreased 38 % after a six-week
incubation in SBF. However, the value was still higher than
that of a human trabecular bone, which suggested that the
scaffolds may be suitable for load-bearing sites.
The use of SLS has been expanded to polymer/ceramic
composites. The major challenge in the fabrication of
porous composite scaffolds using SLS is associated with
finding an optimal combination of the process parameters,
including powder composition, part particle size, laser
power, powder bed temperature, scan speed, scan spacing,
and part orientation that critically influence the mechanical
properties of the scaffolds. The most tested composite
system by the SLS process is PCL/HA (Wiria et al. 2007;
Eosoly et al. 2010; 2012), PCL/TCP (Lohfeld et al. 2012)
and poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV)/
TCP (Duan et al. 2010; Duan and Wang 2010) (Fig. 14).
By optimising the laser power and the scan speed, Wiria
et al. (2007) were able to produce a PCL/HA composite
scaffold with 10, 20 and 30 wt % of HA. The compressive
Young’s modulus of these scaffolds was 34, 24, and
57 MPa, respectively.
The mechanical and biological performances of scaf-
folds in vivo are greatly influenced by their micro-archi-
tectures. Lohfeld et al. (2012) produced PCL/TCP scaffolds
with a range of micro-architectures and compositions using
the SLS technique. In their work, scaffold fabrication from
the composite of up to 50 wt % TCP is demonstrated to be
possible. With increasing porosity, the stiffness of the
scaffolds is seen to drop; however, the stiffness can be
increased by geometrical changes such as the addition of a
cage around the scaffolds, especially for small scaffolds.
However, the in vivo evaluation showed that the perfor-
mance of their scaffolds was not as good as the TCP
control in new bone formation.
Functional gradient scaffolds that mimic the anatomical
geometry of bone have also been produced from PCL using
the SLS technique combined with the CAD design (Chua
Fig. 14 Images of PHBV/TCP composite scaffolds built by SLS: a photograph; and b SEM morphology (Duan et al. 2010)
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et al. 2011). The porosity and compressive stiffness and
yield strengths of their PCL scaffolds are 40–84 %,
3–56 MPa and 0.2–5 MPa, respectively, which are com-
parable to those of cancellous bone in the maxillofacial
region (Sudarmadji et al. 2011).
It is technically difficult to incorporate bioactive mole-
cules in the scaffolds produced by the SLS technique due to
the high temperatures used for melting the powders. Using
the SLS technique, Duan and Wang (2010) fabricated BSA,
loaded CaP/PHBV nanocomposite microspheres into 3D
porous scaffolds with good dimensional accuracy while
retaining the bioactivity of BSA. In addition, protein-loa-
ded microspheres were subjected to the laser sintering
process and the bed temperature of the part was chosen to
be 35 C without further preheating to protect the bioac-
tivity of BSA to the maximal extent.
The scaffolds produced by SLS have been assessed in their
cell attachment, proliferation, differentiation and formation
of bone tissues (Shuai et al. 2013; Zhang et al. 2008; Bael et al.
2013). Zhang et al. (2008) manufactured HA-reinforced
polyethylene and polyamide composites produced by the
SLS process to investigate the biocompatibility of SLS
composites. The results showed good biocompatibility of the
SLS composite processed with no adverse effects observed
on cell viability and metabolic activity, supporting a normal
metabolism and growth pattern for osteoblast.
Advanced SLS technology
To minimise heat transfer, Popov et al. (Popov et al. 2004)
developed a technique of surface selective laser sintering
(SSLS) to fabricate 3D composite scaffolds that are both
bioactive and biodegradable. SSLS is different to conven-
tional SLS in terms of using the laser power and laser inten-
sity. In the conventional SLS process, polymer particles
absorb infrared radiation (k = 10.6 lm) and are completely
melted. Melted polymer particles are then fused with each
other to form a bulk shape. This process involves large vol-
umetric shrinkage. In the SSLS process, a near-infrared laser
radiation (k = 0.97 lm) is used, which is not absorbed by
polymer particles at all. For the sintering purpose, polymer
particles are coated with carbon. Hence, the melting of
polymer is limited to the surface layer of polymer particles.
Since there is no overheating in the particles’ internal region,
the SSLS technology has the potential to maintain the nature
of delicate biomolecules inside the polymer particles during
the scaffold fabrication (Bartolo et al. 2008; Antonov et al.
2005; Kanczler et al. 2009).
Advantages and disadvantages of the SLS process
Most steps of the SLS process are similar to those of SLA,
but the former enables the processing of powder-based
materials by melting or sintering and does not use organic
solvents or any toxic chemicals. The SLS technique also
eliminates the requirement of an additional supporting
structure for the model during processing because unpro-
cessed powders serve as a supporting material. However,
SLS has an inherent shortcoming (i.e. heat transfer reac-
tions by radiation, convection and conduction in the feeders
and in the powder bed) and as a result, the biodegradable
polymer powder is likely to degrade (Pham et al. 2008).
Nevertheless, the investigation by Pereira et al. (2012) on
both processed P3HB powder and unprocessed P3HB
powder has clearly shown that there were no significant
differences between the two groups of P3HB in thermal
values and chemical shift peaks obtained from DSC and
1H-NMR, respectively, indicating that the P3HB powder
which underwent printing sets can be re-utilised to print
additional structures without affecting the reproducibility
of the process. Although the heat generated by the laser
beam may not affect the material property at a short time,
SLS processing of complex-shaped prototypes or large
prototypes typically needs enough time to expose polymers
to a high temperature. Another problem of this technique is
associated with the almost-impossible removal of powder
trapped inside the small hole, which may block cellular
ingrowth and induce an adverse inflammatory reaction.
Similar to SLA, the shrinkage of the parts during melting
or sintering is another principal problem.
3D printing (3DP)
Principle of 3DP
3DP is one of the ink-jet printing techniques that was
developed at the Massachusetts Institute of Technology
(MIT) in 1989. It is employed to create a complex 3D solid
object by selective spraying a liquid binder onto the layer
of the powder bed; this merges particles together to form a
solid layer. The powder bed is then lowered so that a new
powder layer is spread over the surface of the previous
layer by the roller. This process is repeated until the pre-
designed object, which is embedded inside unfused pow-
ders, is obtained. The completed object requires the
removal of the loose powder. The machine diagram of a
3DP is given in Fig. 15. Subsequently, Therics Incorpora-
tion has applied a developed 3DP process named the
TheriFormTM process to produce scaffolds for use in tissue
engineering (Chu 2006; Bartolo et al. 2008; Hopkinson and
Dickens 2006).
3DP applications in tissue engineering
3DP has been widely used to produce scaffolds from a
broad variety of materials, including polymer, hydrogels,
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ceramics and composites. Currently, most research studies
in the 3DP field have focused on evaluating mechanical
property and in vitro and in vivo performances. Kim et al.
(1998) employed 3DP combined with a particular leaching
technique to create a porous PLGA scaffold with an
intrinsic network of interconnected channels for a hepato-
cyte (HC) function study. The pore sizes and porosity of
the scaffold were 45–150 lm and 60 %, respectively.
Sherwood et al. (Sherwood et al. 2002) reported the fab-
rication of a device with two distinct regions (cartilage and
bone) using the TheriFormTM 3DP process. The upper
cartilage region was 90 % porous and composed of
D,L-PLGA/L-PLA. The lower, cloverleaf-shaped bone por-
tion was 55 % porous and consisted of a L-PLGA/TCP
composite as shown in Fig. 16. The transition region
between these two sections contained a gradient of mate-
rials and porosity to prevent delamination. In in vitro
evaluation, chondrocytes preferentially attached to the
cartilage portion of the device, and biochemical and his-
tological analyses showed that cartilage formed during a
6-week culture period.
Ge et al. (2009) reported the fabrication of 3DP-printed
PLGA scaffolds and their mechanical properties, micro-
environment, and biological properties. The results showed
that the PLGA scaffolds examined had mechanical prop-
erties (7.8 MPa) similar to that of trabecular bone
(7.7 MPa), but was still much weaker compared to cortical
bone (193 MPa). In addition, the PLGA scaffolds contain
micropores within their macropore walls. Human osteo-
blasts were found to proliferate upon seeding on the PLGA
scaffolds.
3D printing is the only the solid-phase RP technique that
is compatible with hydrogel manufacturing. Hydrogels
made from PEG/collagen/PDL, PEO/PCL, and starch/
cellulose have been processed with the 3DP system for
biomedical engineering applications. One major drawback
when working with hydrogels is the lack of mechanical
strength. Therefore, a post-treatment step involving infil-
tration and crosslinking with monomers and/or pre-poly-
mer is needed to improve the mechanical stability of the
constructs (Billiet et al. 2012). It is possible to incorporate
biological agents or even living cells into hydrogel scaf-
folds because of the involvement of water in hydrogel.
The 3DP system is applicable for the fabrication of
ceramic-based tissue engineering scaffolds. However, post-
processing with heat treatment is required to achieve higher
density and better mechanical properties of the finished
parts; this is similar to the SLS process that has been
described. Bioceramic powders, such as HA (Roy et al. 2003;
Seitz et al. 2005; Warnke et al. 2010), b-TCP (Warnke et al.
2010; Santos et al. 2012) and bioglass (Meszaros et al. 2011),
have been fabricated into porous scaffolds by the 3DP sys-
tem. In one study, Seitz et al. (2005) reported the possibility
of using the 3DP process chain to build porous HA scaffolds
with internal channels between 450 and 570 lm. The com-
pression strength of the test parts is 21 MPa, falling in the
range of those of human spongy and cortical bone. However,
the scaffolds were not suitable for carrying high forces in
strongly loaded regions in the human skeleton. Likewise, in
the research of Santos et al. (2012), differently shaped b-TCP
scaffolds were fabricated by the 3DP technique using the
patient’s specific CT data. The scaffolds were sintered at
different temperatures to enhance their mechanical proper-
ties. The porosity, bulk density and compression strength are
influenced by parameters such as particle size distribution,
sintering temperatures, sintering time length or the binder’s
concentration. The results showed a good cell–scaffold
interaction.
Another investigation on b-TCP scaffolds was con-
ducted by Fielding et al. (2012). By adjusting the pro-
cessing parameters of 3DP, scaffolds of a high resolution
Fig. 15 Schematic representation of the 3DP system (Fielding et al.
2012)
Fig. 16 A scaffold with two distinct regions: 90 % porous
D,L-PLGA/L-PLA as the cartilage region (upper side) and 55 %
porous cloverleaf-shaped L-PLGA/TCP as the bone region (lower
side) (Sherwood et al. 2002)
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were produced from TCP powders with or without SiO2/
ZnO doping. The addition of dopants into the TCP scaf-
folds was demonstrated to increase the mechanical strength
of the scaffolds, as well as cellular proliferation.
Warnke et al. (2010) investigated the biocompatibility
of HA and TCP scaffolds (Fig. 17) produced using a 3DP/
sintering technique and their ability to support and promote
the proliferation of human osteoblasts compared with the
commonly used bone replacement material, bovine HA
(BioOss). The results showed that both TCP and HA
scaffolds were colonised by human osteoblasts. Cell
vitality staining and biocompatibility tests showed superior
biocompatibility of HA scaffolds to BioOss, while Bi-
oOss was more compatible than TCP.
3DP has been used for the production of polymer/cera-
mic composite scaffolds. The composite scaffolds made
from PLGA/TCP and 55 wt % salt particles for the bone
portion of the osteochondral device were investigated by
Sherwood et al. (2002). The tensile strength and com-
pressive strength of the porous PLGA/TCP scaffolds were
similar in magnitude to fresh cancellous human bone.
In another investigation, Sharaf et al. (2012) fabricated
PCL/TCP (50:50 w/w) composite scaffolds containing
channels of either 1 mm or 2 mm in diameter using a
TheriFormTM machine, and evaluated porcine bone mar-
row-derived progenitor cell (pBMPC) proliferation and
penetration in the scaffolds. The composite scaffolds with
1-mm channels showed greater cellular proliferation, pen-
etration, and collagen formation after a two-week in vitro
cell culture than the scaffolds of 2-mm channels.
Using 3DP, the research team of Parsons et al. (2003;
Simon et al. 2003) fabricated PLGA/TCP scaffolds and
evaluated the effect of prescribed meso-architecture on
bone response in a rabbit model. The results demonstrated
that the scaffolds with engineered macroscopic channels
and a porosity gradient had higher percentages of new
bone area, compared to scaffolds without engineered
channels.
Bergmann et al. (2010) employed 3DP process to pro-
duce a composite of b-TCP and a bioactive glass similar to
the 45S5 Bioglass, using orthophosphoric acid (H3PO4)
and pyrophosphoric acid (H7P2O7) as binders. The maxi-
mum resolution (a layer thickness) of the printed structures
was 50 lm. In the printing process, the glassy phase of the
granules had no effect on the cement reaction. Therefore,
the glass content can be varied to generate tailored bio-
degradation capabilities of the implant. Nevertheless, the
blending strength of 15 MPa is still 10 times lower than
that of natural bone. Winkel et al. (2012) produced scaf-
folds from 13 to 93 Bioglass/HA powder using 3DP fol-
lowed by sintering.
Fierz et al. (2008) studied the effects of different designs
and layers of HA scaffolds with tailored pores on osteo-
blast cell migration and tissue formation. Histological
results showed that cells of different morphology could
fill the micropores of scaffolds produced by the 3DP
technique.
Shanjani et al. (2011) conducted an interesting study in
which they investigated the influence of the orientation of
the stacked layers on the mechanical behaviour of the 3DP-
made calcium polyphosphate (CPP) cylinders. They dem-
onstrated that the scaffolds with layers stacked parallel to
the compressive loading direction were about 48 % stron-
ger than those with the layers stacked perpendicular to the
loading direction. However, the tensile strength values of
the samples were not significantly influenced by the
stacking orientation. This study indicates that the com-
pressive strength of the scaffolds can be tailored by the
orientation of the powder stacking layers within the CPP
structures relative to the loading/stress profile at the
implant site.
Advantages and disadvantages of 3DP process
3DP is a simple, versatile technique that has several
advantages. These include the use of cheap material, the
Fig. 17 Examples of bioceramic scaffolds produced by 3DP: a TCP and HA photograph; b SEM image of TCP; and c SEM image of HA
(Warnke et al. 2010). The magnifications of b and c are the same
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high build speed of the system, and no additional support
structure needed during processing similar to the SLS
system. In particular, it does not require the use of heat or
harsh chemicals, making it friendly for incorporating bio-
logically active molecules inside the scaffolds. However,
the final objects have relatively poor strength due to the
weak bonds between particles, and the limited resolution
and accuracy. Another drawback of the 3DP system is the
rough surface finish of objects due to the large size of
powder particles. Similar to the problems in the SLS pro-
cess, it is difficult to remove the powder particles trapped
inside small cavities of parts; this may be harmful to cells
and tissues. Further, the shrinkage and distortion occur in
the both the printing and sintering process.
Extrusion-based processes
Principle of FDM
The extrusion-based RP, which is commercially known as
the FDM process (Fig. 18), was first developed and com-
mercialised by Stratasys Inc. in 1992. It fabricates 3D
scaffolds by melting and extruding material (normally a
thermoplastic polymer) through a moveable nozzle with a
small orifice onto a substrate platform. The filament
material is fed through two rotating rollers into the extruder
head, where the material can be melted. The nozzle moves
in the x and y directions so that the filament is deposited on
a parallel series of material roads to form a material layer,
and subsequently the build platform in the z direction is
lowered to build the new layer on the top of the first layer.
After the extruded material cools, solidifying itself and
bonding to the previous layer, a 3D structure is yielded. In
general, this technique requires support structures for
overhangs or island features. Recently, the FDM system
was enhanced to have two nozzles. One nozzle is used for
building the material and the second nozzle is used to
extrude a different material for the temporary support
material. After the part is completed, the support structures
would be broken away from the parts (Chu 2006; Bartolo
et al. 2008; Hopkinson and Dickens 2006).
FDM applications in tissue engineering
The FDM process has been used to produce scaffolds from a
wide variety of materials (polymers, ceramics and com-
posites). Zein et al. (2002; Hutmacher et al. 2001, 2008) first
used the FDM technique to create PCL honeycomb-like
scaffolds (the first generation of scaffolds). PCL scaffolds
showed excellent biocompatibility with human fibroblast.
The same group later produced PCL scaffolds with hon-
eycomb-like pattern, fully interconnected channel network,
and controllable porosity and channel size. The PCL
scaffolds were produced with the channel size of
160–170 lm, filament diameter of 260–370 lm and
porosity of 48–77 %, and regular honeycomb pores. The
compressive stiffness ranged from 4 to 77 MPa, with a yield
strength from 0.4 to 3.6 MPa and a yield strain from 4 to
28 %.
Hsu et al. (2007) evaluated PLA and PCL scaffolds
produced via FDM for bone and cartilage regeneration. The
results indicated that the highly porous and interconnected
structure of scaffolds could benefit cell ingrowth. Yen et al.
(2009) fabricated PLGA scaffolds using FDM and modi-
fied them with type II collagen for cartilage-tissue engi-
neering. The seeded chondrocytes were well distributed
inside the hybrid scaffolds with a large spacing of fibre
stacking facilitating the removal of acidic degradation
products, and neo-cartilage tissue was populated in the
scaffolds. Using the FDM process, Tellis et al. (2008)
produced poly(butylene terephthalate) (PBT) trabecular
scaffolds with various pore structures.
The manufacture of bioceramic scaffolds with the FDM
technique can be subdivided into two processes: the fused
deposition of ceramics (FDC) and the lost mould technique
(Leong et al. 2003; Smay and Lewis 2012). The former is a
direct printing technique; the latter is an indirect method.
The FDC technique was developed by Cornejo et al.
(2000). It uses filament as a precursor to fabricate 3D green
ceramic parts. The filament is a composite of thermoplastic
polymer, ceramic powder and binder. The thermoplastic
polymer and binder are removed during post-processing,
and the sintering of the finished ceramic parts is conducted
Fig. 18 Schematic representation of the FDM system (Zein et al.
2002)
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to improve their mechanical properties. The FDC process
can be utilised to create ceramic components for scaf-
folding and bone tissue engineering applications (Danforth
et al. 1998; Onagoruwa et al. 2001; Iyer et al. 2008). The
lost mould technique uses an FDM machine to produce
polymer moulds with a negative structure of the intended
network, and then the ceramic slurry is cast into the mould.
Once the ceramic slurry solidifies, the finished object will
be heated to remove the polymer mould, followed by a
sintering process to consolidate the ceramic structure (Bose
et al. 1999; Hattiangadi and Bandyopadhyay 2000; Kalita
et al. 2003; Bernardo 2010).
The FDM process has been used to produce composite
scaffolds. Hutmacher et al. (2008; Hutmacher and Cool
2007) produced the first generation of FDM scaffolds (e.g.
PCL/HA and PCL/TCP) for bone tissue regeneration
(Fig. 19). The same group has developed the second gener-
ation of scaffolds from different polymers and CaP. These
composite scaffolds exhibited favourable mechanical prop-
erties, degradation and resorption kinetics and bioactivity. In
addition, these scaffolds demonstrated improved cell seed-
ing, and enhanced incorporation and immobilisation of
growth factors. Recently, Bioglass/polymer composite
scaffolds produced via the FDM process were reported by
Korpela et al. (2013). Porous scaffolds were created using
PLA, PCL, and PCL with S53P4 bioactive glasses.
Lam et al. (2009) investigated the in vivo performance
of PCL scaffolds in a rabbit model for up to 6 months.
Histological examination of the in vivo samples revealed
good biocompatibility, with no adverse host tissue reaction
up to 6 months. Zhou et al. (2007) studied the use of
mineralised cell sheets in combination with fully inter-
connected composite scaffolds (PCL/CaP). The scaffolds
were implanted subcutaneously in nude rats. Histological
and immune histochemical examination revealed that
neo-mineralised tissue formed in the constructs and bone
formation followed an endochondral pathway.
The quality of the FDM-build scaffold generally
depends on the road size, the shape, the uniformity and
road consistency. Efforts have been invested to optimise
the processing parameters and improve FDM processing
efficiency. Anitha et al. (2001) assessed the effect of
parameters such as layer thickness, road width and speed
deposition on the quality of the prototypes using the
Taguchi technique. Recently, Ramanath et al. (2008) made
progress in understanding the melt flow behaviour (MFB)
of PCL, which was used as a representative biomaterial.
The MFB significantly affects the quality of the scaffold;
this depends not only on FDM processing parameters but
also on the physical properties of the materials used.
Advantages and disadvantages of the FDM process
The advantages of this technique include its low cost, the
lack of use of organic solvent, the ability to form a fully
interconnected pore network in complex 3D architecture,
and rare or no requirement of cleaning up the finished
objects. This technique allows a flexible fabrication of
interconnected porous scaffolds with compositional or
morphological variation across the entire matrix, with
architecture being highly reproducible. Nonetheless, there
are inherent limitations of raw material selection, which
needs to be used in the form of filaments with specific size.
Other limitations include the effect of high temperatures on
raw material, and the lack of adequate resolution. In
addition, it is limited in the z direction due to the diameter
of the extruded filament (Chen et al. 2007). Hence,
researchers try to modify FDM to overcome these problems
with an attempt to avoid requiring precursor filaments or
operating harsh temperatures, as discussed below.
Fig. 19 SEM images of PCL/
TCP composite scaffolds
obtained from FDM: a structure
of top view with inset of cross-
sectional view; and b osteoblast
cells attached on the scaffold
surface (Zhou et al. 2007)
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Advanced FDM technology
Several modified FDM processes have been proposed for
scaffold fabrication. These include multi-head deposition
system (MHDS), low-temperature deposition manufactur-
ing (LDM), precision extruding deposition (PED), pres-
sure-assisted microsyringe (PAM), robocasting, and 3D-
Bioplotter system (Yeong et al. 2004; Hutmacher et al.
2008; Hoque et al. 2011).
MHDS The MHDS (Fig. 20) involves incorporating
more than one independent extrusion head into the sys-
tem to create a complex composition and geometry of
scaffolds from various biomaterials. This system can
fabricate 3D microstructures with a resolution of several
tens of microns. Kim and Cho (2009) fabricated scaf-
folds from various biomaterials (e.g. PLGA, PCL and
TCP) using MHDS. In their work, the deposition process
was optimised to achieve efficiently a uniform line
width, line height and porosity. Blended 3D PCL/PLGA
scaffolds were fabricated with a fully interconnected
architecture and a porosity of approximately 70 %. The
compressive strength and modulus of the scaffold is
approximately 0.8 and 12.9 MPa, respectively (Kim and
Cho 2009).
The same research group evaluated the PCL/PLGA/TCP
scaffolds using osteoblasts. In vivo study using the calvaria
defect model in rats indicated that scaffolds had the
potential to enhance bone formation at 8- and 12-weeks
implantation (Kim et al. 2010). Later, Lee et al. (2012) also
employed MHDS in the production of PCL/PLGA scaf-
folds (Fig. 21) with different pore architectures (lattice,
stagger, and triangle types) and stacking directions (hori-
zontal and vertical). They found that the mechanical
properties of the triangle-type scaffold were the strongest
among the experimental groups. Stacking direction affec-
ted the mechanical properties of the scaffolds.
A key benefit of using MHDS is the ability to fabricate
scaffolds that accommodate different materials in a single
layer. Nonetheless, using MHDS involves processing at a
high temperature, which leads to the decomposition of
polymer materials. In addition, this technique does not
allow for cell-loaded or drug-loaded scaffold fabrication.
LDM To address the problem associated with the high-
temperature effect on the polymeric biomaterial, another
modified FDM process, LDM (Fig. 22) has been devel-
oped. LDM combines a nozzle extrusion process and a
TIPS (Bartolo et al. 2008). The LDM developed by Xiong
et al. (2002) involves the fabrication of 3D scaffolds in a
low-temperature environment under 0 C to solidify the
material solution when deposited on the platform. Their
PLLA/TCP composite scaffolds have a high porosity of up
to 90 % as demonstrated in Fig. 23a–c. The mechanical
strength values of the scaffolds were close to those of
spongy human bone. The scaffolds were evaluated in vivo,Fig. 20 Schematic representation of MHDS (Kim and Cho 2009)
Fig. 21 SEM images of PCL/
PLGA scaffold fabricated via
MHDS (Lee et al. 2012)
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showing good biocompatibility and good bone conductivity
(Bartolo et al. 2008).
Independently, Li et al. (2011) developed an LDM
system and fabricated PLGA/TCP scaffolds for alveolar
bone repair. The composite scaffolds had porosity up to
87 % and the mechanical properties of the scaffolds were
similar to cancellous bones. These scaffolds showed good
biocompatibility in the attachment and proliferation of
human bone marrow mesenchymal stem cells (HBMSC).
To fabricate scaffolds from heterogeneous materials,
multi-nozzle low-temperature deposition and manufactur-
ing (M-LDM) has been developed. This system offers great
advantages in fabricating scaffolds with gradient porous
structures and gradient biomolecules, which could poten-
tially be used in the reconstruction of multi-tissue or
complicated organs (Yan et al. 2003). Yan et al. (2003)
fabricated bone tissue engineering scaffolds through single-
nozzle deposition, bi-nozzle deposition and tri-nozzle
deposition processes. M-LDM was recently applied by Liu
et al. (2009) to fabricate composite scaffolds with two
types of materials (i.e. PLGA, chitosan collagen and gel-
atine) and TCP via two nozzles, and a satisfactory com-
bination of hydrophilic and mechanical properties was
achieved (Fig. 23d–e).
With the elimination of the heat impact on biomaterials,
LDM and M-LDM have the potential to fabricate the
bioactive tissue scaffolds via the incorporation of biomol-
ecules. The shortcoming of these two techniques is the
necessity for solvent removal via a freeze-drying process,
which is time consuming.
PED To overcome the requirement of filament prepara-
tion in FDM, the modified FDM process known as PED
(Fig. 24) was developed by Wang et al. (2004) for the
fabrication of interconnected 3D scaffolds. This process
employs raw material in the form of pellets that are fed into
a chamber, and then directly extrudes scaffolding materi-
als. Wang and co-workers directly fabricated cellular PCL
scaffolds with a controlled pore size (*250 lm) and
designed structural orientation without involving the
material preparation and indirect casting. The resultsFig. 22 Schematic representation of LDM (Xiong et al. 2002)
Fig. 23 Images of a PLLA/TCP composite scaffold made in LDM
process, SEM images of the cross-section of the scaffold; b low
magnified; c high magnified (Xiong et al. 2002); d multi-material
(PLGA/collagen) scaffold made in M-LDM process; and e SEM
images of the interface of the scaffold (Liu et al. 2009)
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demonstrated that the strut width was consistent between
samples, and all samples showed an interconnective
porosity of higher than 98 %. The compression modulus of
the scaffolds was in a range between 150 and 200 MPa.
Using PED, Shor et al. (2007) produced PCL and PCL/
HA scaffolds that had a porosity of 60 and 70 % (respec-
tively) and pore sizes of 450 and 750 lm (respectively).
In vitro evaluation demonstrated that the fabrication pro-
cess had no adverse cytotoxic effect on the scaffolds.
Porous PCL scaffolds with a pore size of 350 lm and
designed structural orientations (Fig. 25) were later pro-
duced by the same group (Shor et al. 2009). An in vivo
study demonstrated that there was increasing osseous
ingrowth during the 8-week culture period, indicating that
the osteoblast cells were able to attach and proliferate on
the scaffold (Shor et al. 2009). In addition, PED was used
to produce composite scaffolds from poly(L-lactide-co-D,L-
lactide) (PLDLLA)/TCP (Lam et al. 2009) and PCL/TCP
(Arafat et al. 2011) for bone tissue engineering. The
mechanical properties and in vitro cytocompatibility of the
PED-fabricated composite scaffolds exhibited favourable
results.
The PED process has several advantages over conven-
tional FDM techniques in terms of no need of filament
fabrication and the ability to print viscous materials.
However, the major drawback of this technique is that it
does not allow for incorporation of biomacromolecules and
living cells into scaffolds during the processing, due to the
elevated temperature that must be used to melt the mate-
rials. The heat impact at the elevated temperature may also
damage polymeric materials during the processing.
PAM PAM (Fig. 26) is a modified FDM technique
developed by Vozzi et al. (2002) that allows the fabrication
of 3D scaffolds with a well-defined geometry at the micron
scale. A solution of polymer can be extruded through a
narrow capillary needle (diameter of between 10 and
20 lm) by the application of constant pressure of
20–300 mmHg. After the solvent is evaporated, the paste
solidifies. By changing the syringe pressure, solution vis-
cosity, diameter of the syringe tip and processing speed, the
thickness of the materials deposited can be controlled. The
higher the viscosity of the solutions used, the better are the
resolutions that can be achieved. However, to extrude a
solution of viscosities greater than approximately 400 cp
demands high driving pressures, which may break the tip
(Vozzi et al. 2003). This technique has been used for the
deposition of a wide range of polymers and composites
(Vozzi et al. 2003; Rattanakit et al. 2012; Tartarisco et al.
2009; Vozzi et al. 2013).
PAM was used to produce PLGA scaffolds with high
lateral resolution (10–30 lm feature) (Vozzi et al. 2003).
3D PLLA/carbon nanotubes (CNTs) composite scaffolds
(Fig. 27) have been developed by Vozzi et al. (2013) for
bone tissue engineering. The composite structures exhib-
ited improvement in the mechanical properties in com-
parison with the pure 3D PLLA scaffolds. In vitro cell
culture of the scaffolds also showed that they support
osteoblast proliferation.
More recently, the same group further developed PAM
with a new model, piston-assisted microsyringe known as
Fig. 24 Schematic representation of PED (Wang et al. 2004)
Fig. 25 SEM images of a PCL scaffold fabricated via PED; b low magnified; and c high magnified (Shor et al. 2009)
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‘PAM2’ (Vozzi and Ahluwalia 2007; Tirella et al. 2011;
Vozzi et al. 2012), which aimed at the microfabrication of
cell-incorporated hydrogels. Instead of using the air pres-
sure, the new process uses a mechanical piston as the
driving force for extrusion, which allows the control of the
material outflow from the needle tip. Low shear stresses
over short periods are involved during the ejection of cells
without considerable damage of cell membrane. In short,
PAM2 can print the well-defined structures of highly vis-
cous materials incorporated with cells.
The major advantages of this technique are its simplicity
and its fabrication of well-defined 3D scaffolds in a variety
of patterns and with a wide range of thicknesses. It can
produce structures with the highest lateral resolution of
5–10 lm. The operating system at low temperature also
allows for the incorporation of proteins and other biomol-
ecules, which can build favourable microenvironments for
tissue regeneration. The limitations of this technique are
the low vertical dimension, the inability to incorporate
even small particles, and the limited usage for low-con-
centrated solutions. The last two drawbacks are due to
clogging of the syringe needle.
Robocasting Robocasting, also referred to as ‘robotic
deposition’ and ‘direct-write assembly’ (Fig. 28), was
developed at the Sandia National Laboratory (Cesarano
et al. 1998). This technique can lay down a highly con-
centrated, pseudoplastic-like colloidal suspension (water-
based inks) through a small nozzle inside a non-wetting oil
bath. The soft pseudoplastic then becomes a rigid mass
after the evaporation of water from the paste (Smay et al.
2002). This technique has been used to produce porous
ceramic and composite scaffolds with different architec-
tures (Miranda et al. 2006; Hoelzle et al. 2008; Miranda
et al. 2008; Martı´nez-Va´zquez et al. 2010).
Using the robocasting technique, Fu et al. (2011) pre-
pared bioglass scaffolds from the suspension of bioactive
glass (6P53B) in Pluronic F-127 aqueous solution. The
sintered glass scaffolds with 60 % porosity showed a
compressive strength (136 ± 22 MPa) comparable to that
of human cortical bone (100-150 MPa), which is suitable
for load-bearing applications (Fig. 29). In addition, Del-
linger et al. (2006) produced model HA scaffolds of vari-
ous architectures, including periodic, radial, and super-
lattice structures with macropores (100–600 lm), microp-
ores (1–30 lm), and submicron pores (\1 lm). This study
indicates that by precise control of scaffold features, these
model scaffolds may be used to systematically study the
effects of scaffold porosity on bone ingrowth processes
both in vitro and in vivo.
Heo et al. (2009) produced HA/PCL composite scaffolds
using the robocasting process. The macropores in the
scaffolds were well interconnected, with a porosity of 73 %
and a pore size of 500 lm. The compressive modulus of
the nano-HA/PCL and micro-HA/PCL scaffolds was 3.2
and 1.3 MPa, respectively. The higher modulus of nano-
HA/PCL was to be likely caused by the well-dispersed
nanosized HA particles. In addition, the more hydrophilic
surface of nano-HA/PCL, which resulted from the greater
surface area of HA of nano size, could promote cell
attachment and proliferation compared with micro-HA/
Fig. 26 Schematic representation of PAM (Vozzi et al. 2002)
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PCL. Martinez-Vazquez et al. (2010) reported the infiltra-
tion of PCL or PLA into b-TCP porous scaffolds fabricated
by robocasting increased their compressive strength com-
pared with pure calcium phosphate scaffolds.
(PLA or PCL)/(HA, CaP or bioactive glass) composite
scaffolds were fabricated in the robocasting process with
inorganic contents as large as 70 wt % (Russias et al. 2007;
Serra et al. 2013). The addition of PEG to PLA matrix,
combined with other processing parameters, could reduce
the ink viscosity and thus allow for printing high-resolution
3D scaffolds. All these scaffolds showed encouraging
biological response in in vitro evaluations.
Robocasting is a versatile technique that allows the
printing of a range of materials and the fabrication of
scaffolds with a range of architectures spanning distances
up to 1 mm. With the ability of fully supporting its own
weight of suspensions during assembly, the scaffold fabri-
cation requires no sacrificial support material or mould
(Smay et al. 2002). However, the optimisation of ceramic
inks suitable for direct print assembly is a primary concern.
This is because if a ceramic ink contains a content of
ceramic powders that is too low, it will dry quickly resulting
in microcracks in the products (Miranda et al. 2006).
3D-Bioplotter 3D-Bioplotter (Fig. 30) is another var-
iant of the FDM technique for fabricating scaffolds, espe-
cially for the soft-tissue engineering purposes. This
technique was developed by the researchers at the Freiburg
Materials Research Centre (Landers et al. 2002; Gurr and
Mu¨lhaupt 2012). While other extrusion-based methods
deposit materials onto a solid platform, this technique
involves moving an extruder head to dispense plotting
material into a liquid medium. The extruder head is made
of a micro needle and a cartridge where liquids, solutions,
dispersion polymers, pastes, hot melts or reactive oligo-
mers are initially stored. The plotting material solidifies in
the liquid medium, which compensates the gravity with a
buoyancy force. As a result, no support structure is
required.
Using the 3D-Bioplotter technique, Lander and Pfister
(Landers et al. 2002) printed alginate/fibrin hydrogel
scaffolds with internal pore sizes of 200–400 lm and
porosity of 40–50 %. The hydrogel scaffolds were further
surface coated to facilitate cell adhesion and cell growth
(Landers et al. 2002). Lode et al. (2012) have recently
produced HA cement scaffolds using the 3D-Bioplotter
technique. To date, this technique has been used to fabri-
cate scaffolds from a number of biomaterials, including
PCL (Oliveira et al. 2009; Ye et al. 2010), PLGA (Daoud
et al. 2011), poly(ethylene oxide terephthalate)-co-
poly(butylene terephthalate) (PEOT/PBT) (Bettahalli et al.
2013), and starch-based blends (Martins et al. 2009; Sobral
Fig. 28 Schematic representation of robocasting (Martı´nez-Va´zquez
et al. 2010)
Fig. 29 SEM images of a surface view of a glass (6P53B) scaffold with a gradient pore size; and b cross sections of the scaffold (Fu et al. 2011)
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et al. 2011; Oliveira et al. 2010). Figure 31 presents the
example of starch-based scaffolds fabricated via the 3D-
Bioplotter system.
The usage of the 3D-Bioplottersystem offers opportu-
nities for fabricating scaffolds from a broad range of
materials and for incorporating biological entities such as
biomolecules, proteins, and even living cells, into the
structures under the physiologically relevant temperature.
The major drawbacks of this technique are that the hydro-
gels produced by 3D-Bioplotter have a limited resolution,
lack mechanical strength, and have a smooth surface that
might be non-adherent for cells (Landers et al. 2002).
Comparison of scaffolding techniques
Among various SFF techniques, SLA, SLS, 3DP and FDM
have been used in the scaffold fabrication, especially for
applications in bone tissue engineering. Figure 32 shows
typical structures of porous scaffolds produced by different
SFF techniques. This section aims to provide a comparison
of the above four systems.
SLA
SLA offers several advantages over other SFF techniques
for scaffold fabrication:
1. SLA offers high spatial accuracy at dimensional
resolutions below 50 lm.
2. The feature of size can be possible at below 1 lm.
3. SLA provides a high-surface quality of parts.
However, there are several limitations of SLA,
including:
1. SLA requires expensive machinery.
2. SLA requires support structures to prevent damage to
the part surface when removed.
3. The construction time involved in SLA could be
lengthy, depending on the design resolution and size.
4. The choice of photo-sensitive resins available in
commercial markets is limited, and most resins are
toxic to cells.
SLS
SLS offers several benefits over other SFF techniques for
scaffold fabrication:
1. The SLS process allows for the fabrication of scaffolds
with a controlled structure.
2. A wide range of biomaterials (polymers, ceramics and
composites) can be processed.
3. SLS can fabricate highly interconnected porous scaf-
folds with a pore size of 50 lm or less.




Fig. 30 Schematic representation of 3D-Bioplotter (Landers et al.
2002; Gurr and Mu¨lhaupt 2012)
Fig. 31 SEM micrographs of a a scaffold obtained with the 3D-Bioplotter technology; b cross-sectional view of the scaffold; and c the surface
morphology (Oliveira et al. 2010)
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The limitations of SLS include the following:
1. The high temperature in the bed powder can allow the
thermal degradation of materials.
2. The resolution of the SLS system is limited by the
shape, size and size distribution of powders used.
3. Removing unprocessed powders trapped into the small
hole of scaffolds is difficult.
3D-printing
3DP offers several benefits over other SFF techniques for
scaffold fabrication:
1. 3DP can create scaffolds with high consistency and
controlled structural anisotropy.
2. 3DP does not involve high temperature, harsh chem-
icals, and support structures.
3. The high building speed of the print head makes the
mass production of scaffolds possible.
4. It is possible to incorporate biological agents into the
scaffolds if the binder is water.
The limitations of the 3DP process include the
following:
1. The layer thickness relies on the particle size of the
powder used.
2. 3DP-fabricated scaffolds have a rough and ribbed
surface finish, which affects the resolution and accu-
racy of the parts.
3. The scaffolds are relatively fragile and lack mechan-
ical stability.
4. The unprocessed powders trapped in small pores of the
parts are difficult to remove.
FDM
FDM offers several benefits over other SFF techniques for
scaffold fabrication:
Fig. 32 3D scaffolds
manufactured by various SFF
techniques: a SLA; b SLS;
c 3DP; and d FDM (Dalton
et al. 2009)
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A high degree of precision can be achieved in the
x–y direction.
2. The versatility in the number of lay-down patterns
allows for freedom to print materials in any direction
within each consecutive layer of an FDM structure.
3. The FDM technique is capable of fabricating scaffolds
with good structural integrity and mechanical stability
because of the proper fusion between individual
material layers.
4. Material wastage is minimal because of direct
extrusion.
The limitations of the FDM process include:
1. FDM is limited to the use of filament materials with
good melt viscosity properties.
2. There is a need to use a high temperature to melt
materials, which results in damage to materials.
3. Control of the z direction can be difficult.
4. The support structure required during processing is
rather difficult to remove, and may cause the risk of
material contamination.
5. Mass production of scaffolds is difficult due to its slow
build speed.
Table 10 summarises the resolution, accuracy, porous
structures and mechanical property of the 3D scaffolds
produced through different SFF techniques, as well as the
advantages and disadvantages of each SFF technique.
Summary
The use of conventional fabrication techniques (such as
solvent casting in combination with particulate leaching,
gas foaming, phase separation, freeze-drying, electrospin-
ning, powder-forming processes and sol–gel techniques)
for ceramic fabrication has a limited capacity to control the
internal and external architecture of scaffolds in dimension,
pore morphology, pore size, pore interconnectivity and
overall porosity. The scaffolds fabricated using the
conventional methods suffer from insufficient mechanical
integrity.
SFF offers several benefits over conventional fabrication
techniques, including high flexibility in shape and size,
capabilities of precise control over spatial distribution, high
reproducibility, and suitability to a broad variety of bio-
materials, and customised design with specific patient
needs. Currently, SLA, SLS, 3DP and FDM are most fre-
quently used in the fabrication of scaffolds from polymers,
ceramics and their composites. Depending on the type of
materials and their specific form, each SFF technique
provides unique internal and external features of scaffold
architectures. Among these SFF techniques, SLA and FDM
have unique benefits and have been extensively studied for
producing 3D structures that enable good mechanical and
biological properties throughout the entire scaffold. SLA
can create tissue engineering scaffolds with excellent
accuracy and good surface quality. FDM offers versatile
fabrication in lay-down pattern and good structural integ-
rity. In addition, both systems are able to fabricate parts
with good mechanical integrity (Table 11) over the pow-
der-based system (3DP) due to proper fusion bonding
between individual material layers.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
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